What Characteristics at Baseline Are Associated with the Glucose-Lowering Effect of Colestimide in Patients with Type 2 Diabetes with Hypercholesterolemia?

被引：0
|
作者：
Suzuki, Tatsuya
Watanabe, Kentaro
Ouchi, Motoshi
Suzuki, Kazunari
Sekimizu, Kenichi
Nakano, Hiroshi
Oba, Kenzo
机构：
来源：
DIABETES | 2011年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2354-PO
引用
收藏
页码：A626 / A626
页数：1
相关论文
共 50 条
  • [21] Effect of colestimide therapy for glycemic control in type 2 diabetes mellitus with hypercholesterolemia
    Yamakawa, Tadashi
    Takano, Tatsuro
    Utsunomiya, Hirotoshi
    Kadonosono, Kazuaki
    Okamura, Atushi
    ENDOCRINE JOURNAL, 2007, 54 (01) : 53 - 58
  • [22] Effects of glucose-lowering drugs on cardiovascular outcomes in patients with type 2 diabetes: an update
    Tomlinson, Brian
    Chan, Paul
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2024, 20 (04) : 175 - 179
  • [23] THE RELATIONSHIP BETWEEN GLUCOSE-LOWERING MEDICATIONS, ADHERENCE, AND OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES
    Piercy, J.
    Milligan, G.
    Davies, M. J.
    Detournay, B.
    Orozco Beltran, D.
    Chubb, B.
    Bottomley, J. M.
    Nicolucci, A.
    Jacob, S.
    VALUE IN HEALTH, 2015, 18 (07) : A343 - A343
  • [24] Initiation of glucose-lowering therapy in Type 2 diabetes mellitus patients in general practice
    Spoelstra, JA
    Stolk, RP
    Klungel, OH
    Erkens, JA
    Rutten, GEHM
    Leufkens, HGM
    Grobbee, DE
    DIABETIC MEDICINE, 2004, 21 (08) : 896 - 900
  • [25] A Decision Support Tool for Appropriate Glucose-Lowering Therapy in Patients with Type 2 Diabetes
    Javier Ampudia-Blasco, F.
    Benhamou, Pierre Yves
    Charpentier, Guillaume
    Consoli, Agostino
    Diamant, Michaela
    Gallwitz, Baptist
    Khunti, Kamlesh
    Mathieu, Chantal
    Ridderstrale, Martin
    Seufert, Jochen
    Tack, Cees
    Vilsboll, Tina
    Tra-Mi Phan
    Stoevelaar, Herman
    DIABETES TECHNOLOGY & THERAPEUTICS, 2015, 17 (03) : 194 - 202
  • [26] FACTORS ASSOCIATED WITH GLUCOSE-LOWERING DRUG ADHERENCE AMONG US ADULTS WITH TYPE 2 DIABETES
    Niu, S.
    Alkhuzam, K.
    Huang, W.
    Tang, H.
    Varghese, J. S.
    Jiao, T.
    Zhang, Y.
    Guo, S.
    Shao, H.
    VALUE IN HEALTH, 2023, 26 (06) : S340 - S340
  • [27] Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes RESPONSE
    Tsapas, Apostolos
    Karagiannis, Thomas
    Avgerinos, Ioannis
    Matthews, David R.
    Bekiari, Eleni
    ANNALS OF INTERNAL MEDICINE, 2021, 174 (01) : 141 - 141
  • [28] Glucose-lowering therapies in type 2 diabetes: Opportunities and challenges for peptides
    Bailey, Clifford J.
    PEPTIDES, 2018, 100 : 9 - 17
  • [29] Cardiovascular outcome trials of glucose-lowering strategies in type 2 diabetes
    Yudkin, John S.
    Vijan, Sandeep
    Sussman, Jeremy B.
    Lehman, Richard
    Goldacre, Ben M.
    LANCET, 2014, 384 (9948): : 1095 - 1095
  • [30] INFLUENCE OF GLUCOSE-LOWERING STRATEGIES ON FRACTURE RISK IN TYPE 2 DIABETES
    Gusova, A. A.
    Pavlova, M. G.
    Melnitchenko, G. A.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 : S160 - S161
12345